Difference between revisions of "Urothelial carcinoma"

Jump to navigation Jump to search
Line 203: Line 203:


Note:
Note:
*PSA positivity is reported in 1.4% of UCC in a larger series.<ref name=pmid19192675>{{Cite journal  | last1 = Chen | first1 = JC. | last2 = Ho | first2 = CL. | last3 = Tsai | first3 = HW. | last4 = Tzai | first4 = TS. | last5 = Liu | first5 = HS. | last6 = Chow | first6 = NH. | last7 = Yang | first7 = WH. | last8 = Cheng | first8 = HL. | title = Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder. | journal = Anticancer Res | volume = 28 | issue = 6B | pages = 4149-54 | month =  | year =  | doi =  | PMID = 19192675 }}
*In a large series, PSA positivity is reported in 1.4% bladder UCC.<ref name=pmid19192675>{{Cite journal  | last1 = Chen | first1 = JC. | last2 = Ho | first2 = CL. | last3 = Tsai | first3 = HW. | last4 = Tzai | first4 = TS. | last5 = Liu | first5 = HS. | last6 = Chow | first6 = NH. | last7 = Yang | first7 = WH. | last8 = Cheng | first8 = HL. | title = Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder. | journal = Anticancer Res | volume = 28 | issue = 6B | pages = 4149-54 | month =  | year =  | doi =  | PMID = 19192675 }}
</ref>
</ref>
**In half the case the staining is weak and in the other half strong.<ref name=pmid19192675/>
**In half the case the staining is weak and in the other half strong.<ref name=pmid19192675/>
48,460

edits

Navigation menu